These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 19058317)
21. Computed tomography during arterial portography prior to transcatheter arterial therapy in hepatocellular carcinoma with marked portal extension: four case reports. Matsuoka Y; Ohtomo K; Yanagidaira H; Okubo T; Kojima K; Nishikawa J; Sasaki Y Eur J Radiol; 1991; 13(3):192-5. PubMed ID: 1661674 [TBL] [Abstract][Full Text] [Related]
22. Therapeutic value of transcatheter arterial chemoembolization combined with portal vein embolization for primary hepatocellular carcinoma with portal vein tumor thrombus: a pilot study. Tan X; Xie P; Liu J; Wu H; Xie Y Asia Pac J Clin Oncol; 2015 Sep; 11(3):e6-e12. PubMed ID: 25228074 [TBL] [Abstract][Full Text] [Related]
23. Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis. Terasawa M; Allard MA; Golse N; Sa Cunha A; Cherqui D; Adam R; Saiura A; Vibert E Surgery; 2020 Feb; 167(2):425-431. PubMed ID: 31780050 [TBL] [Abstract][Full Text] [Related]
24. ALPPS Versus Portal Vein Embolization for Hepatitis-related Hepatocellular Carcinoma: A Changing Paradigm in Modulation of Future Liver Remnant Before Major Hepatectomy. Chan A; Zhang WY; Chok K; Dai J; Ji R; Kwan C; Man N; Poon R; Lo CM Ann Surg; 2021 May; 273(5):957-965. PubMed ID: 31305284 [TBL] [Abstract][Full Text] [Related]
26. Radiological response and inflammation scores predict tumour recurrence in patients treated with transarterial chemoembolization before liver transplantation. Nicolini D; Agostini A; Montalti R; Mocchegiani F; Mincarelli C; Mandolesi A; Robertson NL; Candelari R; Giovagnoni A; Vivarelli M World J Gastroenterol; 2017 May; 23(20):3690-3701. PubMed ID: 28611522 [TBL] [Abstract][Full Text] [Related]
27. Preoperative Sequential Portal and Hepatic Vein Embolization in Patients with Hepatobiliary Malignancy. Hwang S; Ha TY; Ko GY; Kwon DI; Song GW; Jung DH; Kim MH; Lee SK; Lee SG World J Surg; 2015 Dec; 39(12):2990-8. PubMed ID: 26304608 [TBL] [Abstract][Full Text] [Related]
28. Percutaneous portal vein embolization increases the feasibility and safety of major liver resection for hepatocellular carcinoma in injured liver. Azoulay D; Castaing D; Krissat J; Smail A; Hargreaves GM; Lemoine A; Emile JF; Bismuth H Ann Surg; 2000 Nov; 232(5):665-72. PubMed ID: 11066138 [TBL] [Abstract][Full Text] [Related]
29. Complete necrosis of hepatocellular carcinoma after preoperative portal vein embolization: a case report. El Bacha H; Salihoun M; Kabbaj N; Benkabbou A J Med Case Rep; 2017 Jan; 11(1):7. PubMed ID: 28049508 [TBL] [Abstract][Full Text] [Related]
31. Long-term prognosis after arterio-portal embolization for hepatocellular carcinoma. Mamada Y; Tajiri T; Akimaru K; Yoshida H; Taniai N Hepatogastroenterology; 2004; 51(55):234-6. PubMed ID: 15011871 [TBL] [Abstract][Full Text] [Related]
32. Uses and limitations of portal vein embolization for improving perioperative outcomes in hepatocellular carcinoma. Truty MJ; Vauthey JN Semin Oncol; 2010 Apr; 37(2):102-9. PubMed ID: 20494702 [TBL] [Abstract][Full Text] [Related]
33. Transcatheter arterial chemoembolization for hepatocellular carcinoma after attempted portal vein embolization in 25 patients. Kang BK; Kim JH; Kim KM; Ko GY; Yoon HK; Gwon DI; Sung KB AJR Am J Roentgenol; 2009 Nov; 193(5):W446-51. PubMed ID: 19843726 [TBL] [Abstract][Full Text] [Related]
34. Pathologic response to preoperative transarterial chemoembolization for resectable hepatocellular carcinoma may not predict recurrence after liver resection. Paik KY; Kim EK Hepatobiliary Pancreat Dis Int; 2016 Apr; 15(2):158-64. PubMed ID: 27020632 [TBL] [Abstract][Full Text] [Related]
35. Appropriate treatment strategies improve survival of hepatocellular carcinoma patients with portal vein tumor thrombus. Ye JZ; Zhang YQ; Ye HH; Bai T; Ma L; Xiang BD; Li LQ World J Gastroenterol; 2014 Dec; 20(45):17141-7. PubMed ID: 25493028 [TBL] [Abstract][Full Text] [Related]
36. Development of portal vein invasion and its outcome in hepatocellular carcinoma treated by transcatheter arterial chemo-embolization. Chen SC; Hsieh MY; Chuang WL; Wang LY; Chang WY J Gastroenterol Hepatol; 1994; 9(1):1-6. PubMed ID: 8155859 [TBL] [Abstract][Full Text] [Related]
37. Absence of Benefit of Transcatheter Arterial Chemoembolization (TACE) in Patients with Resectable Solitary Hepatocellular Carcinoma. Ha TY; Hwang S; Lee YJ; Kim KH; Ko GY; Ii Gwon D; Ahn CS; Moon DB; Song GW; Jung DH; Lee HC; Lim YS; Kim KM; Shim JH; Choi JH; Lee SG World J Surg; 2016 May; 40(5):1200-10. PubMed ID: 26666422 [TBL] [Abstract][Full Text] [Related]
38. Re-evaluation of lipiodolized transarterial chemoembolization therapy for intrahepatic recurrence of hepatocellular carcinoma after curative liver resection. Eguchi S; Matsumoto S; Hamasaki K; Takatsuki M; Hidaka M; Tajima Y; Sakamoto I; Kanematsu T J Hepatobiliary Pancreat Surg; 2008; 15(6):627-33. PubMed ID: 18987934 [TBL] [Abstract][Full Text] [Related]
39. Laparoscopic radiofrequency ablation combined with laparoscopic liver resection for more than one HCC on cirrhosis. Belli G; D'Agostino A; Fantini C; Cioffi L; Belli A; Russolillo N; Langella S Surg Laparosc Endosc Percutan Tech; 2007 Aug; 17(4):331-4. PubMed ID: 17710062 [TBL] [Abstract][Full Text] [Related]
40. Efficacy and safety of preoperative chemoembolization for resectable hepatocellular carcinoma with portal vein invasion: a prospective comparative study. Zhang YF; Guo RP; Zou RH; Shen JX; Wei W; Li SH; OuYang HY; Zhu HB; Xu L; Lao XM; Shi M Eur Radiol; 2016 Jul; 26(7):2078-88. PubMed ID: 26396105 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]